Historical record - last NADAC effective date: 5/17/2023
Product Information
TUSSIN CF MULTI-SYMPTOM COLD is a generic product labeled by Cardinal Health, priced at $0.0165 per ML under NDC 70000013301. Its NADAC has been published 281 times since Jan 3, 2018.
Strength
20; 200; 10 mg/10mL; mg/10mL; mg/10mL
Manufacturer
Cardinal HealthNDC
70000013301
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
5/17/2023
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/31/2017
Pharmacological Classes
Price Statistics
The NADAC for TUSSIN CF MULTI-SYMPTOM COLD has been published 281 times since Jan 3, 2018, and over the history we have for it it has risen 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0165 per ML |
|---|---|
| All-time high | $0.0222 (Oct 14, 2020) |
| All-time low | $0.0138 (Mar 17, 2021) |
| Median price | $0.0173 |
| Average price | $0.0176 |
| Largest weekly change | +22.7% (Apr 21, 2021) |
| Weeks tracked | 281 |
| Tracking since | Jan 3, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-5.8%
All
+10.8%
Last surveyed May 17, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TUSSIN CF MULTI-SYMPTOM COLD?
The current National Average Drug Acquisition Cost (NADAC) for TUSSIN CF MULTI-SYMPTOM COLD, manufactured by Cardinal Health, is $0.0165 per ML (NDC 70000013301), effective May 17, 2023.
How has the price of TUSSIN CF MULTI-SYMPTOM COLD changed over time?
Over the history we have for it, the NADAC for TUSSIN CF MULTI-SYMPTOM COLD has risen 10.8%. It has been tracked across 281 weekly CMS publications since Jan 3, 2018.
What are the highest and lowest recorded NADAC prices for TUSSIN CF MULTI-SYMPTOM COLD?
Since Jan 3, 2018, the NADAC for TUSSIN CF MULTI-SYMPTOM COLD has ranged from a low of $0.0138 (Mar 17, 2021) to a high of $0.0222 (Oct 14, 2020), with a median of $0.0173 per ML.
Are there cheaper alternatives to TUSSIN CF MULTI-SYMPTOM COLD?
No other NADAC-published product currently shares the active ingredient and strength of TUSSIN CF MULTI-SYMPTOM COLD in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TUSSIN CF MULTI-SYMPTOM COLD?
TUSSIN CF MULTI-SYMPTOM COLD (NDC 70000013301) is labeled by Cardinal Health, and CMS classifies it as a generic product.